TQB3702 placebo

DRUG2 trials

Sponsors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Conditions

Systemic Lupus Erythematosus

Phase 1

A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacokinetic of TQB3702 Tablets in Healthy Adult Subjects

RecruitingNCT06448273

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Systemic Lupus Erythematosus

Start: 2024-07-19End: 2024-10-31Target: 40Updated: 2024-08-12

Phase 2

Clinical Trial of TQB3702 Tablets in Subjects With Systemic Lupus Erythematosus (SLE)

Not yet recruitingNCT06859931

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.Systemic Lupus Erythematosus

Start: 2025-03-31End: 2026-12-31Target: 120Updated: 2025-03-05